<?xml version="1.0" encoding="UTF-8"?>
<p id="Par46">This study will be conducted as a single centre prospective randomised phase II trial in patients with multiple brain metastases and good prognosis (&gt; 6 months). The patients will be compared between the 2 arms: HA-WBRT (control) vs. HA-SIB-WBRT (experimental). The target recruitment is 100 patients over 2 years.</p>
